FNY Managed Accounts’s DMK Pharmaceuticals Corporation Common Stock DMK Stock Holding History
Bought
Maintained
Sold
Other funds holding DMK
BA
LCM
FNY Managed Accounts's DMK Position: Q1 2018 in Review
FNY Managed Accounts held its DMK Pharmaceuticals Corporation Common Stock (DMK) position steady in Q1 2018 at 11 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #450.
FNY Managed Accounts first reported a position in DMK in Q4 2017 and has held it in 2 quarters since. The position peaked at $3K in Q4 2017. 52 funds tracked by Wall St. Rank hold DMK as of Q1 2018.
- FNY Managed Accounts held 11 shares of DMK Pharmaceuticals Corporation Common Stock worth $2K as of Q1 2018.
- FNY Managed Accounts left its DMK Pharmaceuticals Corporation Common Stock share count unchanged in Q1 2018.
- DMK Pharmaceuticals Corporation Common Stock made up ﹤0.01% of FNY Managed Accounts's portfolio in Q1 2018, its #450 holding.
- FNY Managed Accounts first reported a position in DMK Pharmaceuticals Corporation Common Stock in Q4 2017 and has held it in 2 quarters since.
- FNY Managed Accounts's DMK Pharmaceuticals Corporation Common Stock position peaked at $3K in Q4 2017.
- 52 funds tracked by Wall St. Rank held DMK Pharmaceuticals Corporation Common Stock as of Q1 2018.
Based on FNY Managed Accounts's 13F filing for Q1 2018, filed 18 Apr 2018.